Heather K. Beasley was among the researchers who visited Washington, D.C to push for sustained NIH funding during AACR...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
After being diagnosed with stage 4 stomach cancer, Debbie Zelman, Esq., started Debbie’s Dream Foundation: Curing Stomach Cancer (DDF)...
Eddy Shih-Hsin Yang, MD, PhD, associate professor and Regional Oncology Active Research (ROAR) Southeast Cancer Foundation Endowed Chair at...
Guest post by Michele R. McCorkle, RN, MSN Executive Director, Oncology Nursing Society
A half marathon is a challenging goal for anyone. Several members of the American Association for Cancer Research (AACR)...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Jamie Holloway, a breast cancer researcher turned breast cancer patient and AACR Scientist↔Survivor Program advocate, started a blog to...
The American Association for Cancer Research held two community events this week aimed at engaging the public in the...
Guest Post by Roswell Park Cancer Institute Department of Public Affairs
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...